Stocks · Health care · Pharmaceutical Preparations

CYPHERPUNK TECHNOLOGIES INC.

CYPH Clue Score23
United States Fiscal year ends December CIK 0001509745 Results filed 12 Aug 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
BeiGene, Ltd.
24 Sep 2021
10% owner
Buy
2,543,800
$2.85
$7.25M
Perceptive Advisors LLC
22 Jun 2020
10% owner
Buy indirect
1,750,000
$2.00
$3.50M
HealthCare Ventures IX, L.P.
5 Feb 2019
10% owner
Buy
571,428
$1.75
$1,000.00K
Christopher Mirabelli
5 Feb 2019
CEO, President, Chairman
Buy indirect
571,428
$1.75
$1,000.00K
Augustine Lawlor
5 Feb 2019
Chief Operating Officer
Buy indirect
571,428
$1.75
$1,000.00K
Douglas E Onsi
5 Feb 2019
CFO, GC, Treasurer & Secretary
Buy indirect
571,428
$1.75
$1,000.00K
Augustine Lawlor
14 Nov 2017
Chief Operating Officer
Buy indirect
1,057,769
$6.09
$6.44M
Christopher Mirabelli
14 Nov 2017
CEO, President, COB
Buy indirect
1,057,769
$6.09
$6.44M
HealthCare Ventures IX, L.P.
14 Nov 2017
10% owner
Buy
1,057,769
$6.09
$6.44M
Douglas E Onsi
14 Nov 2017
CFO, GC, Treasurer & Secretary
Buy indirect
1,057,769
$6.09
$6.44M

What was left out

Form 4 filings counted 262
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 10
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 9
Transactions with no price 0
Shares from compensation/vesting 48,274,562
History held since 23 Jan 2017